FDA Inspection 1167531 — Innovative Blood Resources, A Division of New York Blood Center Inc

Innovative Blood Resources, A Division of New York Blood Center Inc — FEI 1000221043

The FDA completed an inspection of Innovative Blood Resources, A Division of New York Blood Center Inc on March 24, 2022 in Coon Rapids, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 24, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Coon Rapids, MN (United States)